> ## Content Index
> Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# ICON
- URL: https://www.whiteroseintelligence.com/icon/
- Published: 1999-01-02T18:00:00.000Z
- Updated: 2025-01-20T23:04:31.000Z
- Author: Liam Sturgess
- Tags: Profiles, #docs, #organization

**ICON plc** is a multinational clinical research organization based in Ireland.

## History

On April 27, 2020, ICON signed an "Other Transaction Authority for Prototype Agreement" with the [United States Department of Defense](https://www.whiteroseintelligence.com/United-States-Department-of-Defense) through the Natick Contracting Division "to perform research and development of medical countermeasures (MCMs) through completion of Phase I, II, and III human clinical trials and surveillance studies that demonstrate the efficacy and safety of products that treat, diagnose and/or protect against SARS-CoV2/COVID-19."[\[1\]](#fn1)

ICON sponsored the [17th Workshop on Recent Issues in Bioanalysis](https://www.whiteroseintelligence.com/17th-Workshop-on-Recent-Issues-in-Bioanalysis) on June 19-23, 2023.[\[2\]](#fn2)

In October 2023, [OpenVAET](https://www.whiteroseintelligence.com/OpenVAET) and [DailyClout](https://www.whiteroseintelligence.com/DailyClout) asserted that ICON appeared to use manipulated randomization numbers in order to reveal participant information to [Pfizer](https://www.whiteroseintelligence.com/Pfizer) during the [Pfizer-BioNTech COVID-19 vaccine](https://www.whiteroseintelligence.com/Pfizer-BioNTech-COVID-19-vaccine) clinical trial.[\[3\]](#fn3)

## Organization

ICON is a member of the [Medical CBRN Defense Consortium](https://www.whiteroseintelligence.com/Medical-CBRN-Defense-Consortium),[\[4\]](#fn4) the Corporate Council of the National Organization for Rare Disorders (NORD),[\[5\]](#fn5) and the [Rapid Response Partnership Vehicle](https://www.whiteroseintelligence.com/Rapid-Response-Partnership-Vehicle) (RRPV) Consortium,[\[6\]](#fn6) and is partnered with the Sabin Vaccine Institute.[\[7\]](#fn7)

### Personnel

| Name          | Position                                          | Notes                                                                                                                                                       |
| ------------- | ------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Greg Licholai | Chief Medical and Innovation Officer[\[8\]](#fn8) | [COVID-19 Research Database](https://www.whiteroseintelligence.com/COVID-19-Research-Database), McKinsey & Company, Elpidera, Immunome, PRA Health Sciences |

## External links

- [LinkedIn](https://www.linkedin.com/company/icon-government-and-public-health-solutions-icon-gphs/)
- [Website](https://www.iconplc.com/)
- [Wikipedia](https://en.wikipedia.org/wiki/ICON%5FPLC)

---

1. *Other Transaction Authority for Prototype Agreement between ICON Government and Public Health Solutions, Inc. and Natick Contracting Division.* (2020, April 27). Knowledge Ecology International. <https://web.archive.org/web/20231007173416/https://www.keionline.org/misc-docs/FOIA/DoD-Icon-OTA-Contract-W911QY2090007-27April2020.pdf> [↩︎](#fnref1)
2. *Sponsors & Exhibition.* WRIB. Retrieved May 27, 2023, from <http://archive.today/2023.05.27-180506/https://www.wrib.org/sponsorship-exhibition.php> [↩︎](#fnref2)
3. OpenVAET. (2023, October 7). *Pfizer/BioNTech C4591001 Trial - DailyClout Report 86 on Process 2.* OpenVAET’s Substack. <http://archive.today/2023.10.07-110524/https://openvaet.substack.com/p/pfizerbiontech-c4591001-trial-dailyclout> [↩︎](#fnref3)
4. *Current Members.* MCDC. Retrieved January 3, 2023, from <http://archive.today/2023.01.03-195328/https://www.medcbrn.org/current-members/> [↩︎](#fnref4)
5. *Current NORD Corporate Council Members.* NORD (National Organization for Rare Disorders). Retrieved October 12, 2022, from <https://web.archive.org/web/20221012043656/https://rarediseases.org/get-involved/corporate-council/current-members/> [↩︎](#fnref5)
6. *Current Members.* Rapid Response Partnership Vehicle (RRPV). Retrieved January 19, 2025, from <https://www.rrpv.org/current-members/> [↩︎](#fnref6)
7. *Partners.* Sabin Vaccine Institute. Retrieved September 19, 2022, from <https://web.archive.org/web/20220919064702/https://www.sabin.org/web/20220919064702/https://www.sabin.org/partners/> [↩︎](#fnref7)
8. *Leadership team.* ICON Plc. Retrieved June 1, 2024, from <https://web.archive.org/web/20240601194723/https://www.iconplc.com/about/leadership> [↩︎](#fnref8)